Self Glucose Monitoring Comprehensive Study by Type (Continuous Glucose Monitor (CGM), Blood Glucose Meter), Sales (Online, Offline), Catagories (Blood-Glucose Meters, Blood Glucose Test Strips, Others), Verticals (Patients, Doctors, Others) Players and Region - Global Market Outlook to 2030

Self Glucose Monitoring Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Self Glucose Monitoring
Self glucose monitoring is a method where people with diabetes measure their blood sugar themselves using a glycemic reader. As per the reading, they can adjust or check the effect of their treatment. It is an integral part of intensive glycemic treatment and is widely believed to improve the control of blood glucose levels and health outcomes.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Self Glucose Monitoring is a fragmented market with various key players. The key players are focusing on new product launching to support people's needs and ease the burdens of diabetes management. As well the players invest in partnerships, mergers, and acquisitions to enhance their market presence and to launch programs to support people living with diabetes with evidence-based interventions. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Diabetes Québec (Diabète Québec) (Canada), LifeScan (United States), Hoffmann-La Roche AG (Switzerland), Medtronic (Ireland), Ascensia Diabetes Care (Switzerland), Tandem Diabetes Care (United States), Dexcom Inc. (United States), SocialDiabetes (Spain), One Drop (United States) and H2 Inc. (Taiwan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Dottli (Finland) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Self Glucose Monitoring market by Type (Continuous Glucose Monitor (CGM) and Blood Glucose Meter) and Region.



On the basis of geography, the market of Self Glucose Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales, the sub-segment i.e. Online will boost the Self Glucose Monitoring market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Catagories, the sub-segment i.e. Blood-Glucose Meters will boost the Self Glucose Monitoring market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Verticals, the sub-segment i.e. Patients will boost the Self Glucose Monitoring market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Diabetic Patients and Technological Advancement and Digitalization over the Globe

Market Growth Drivers:
Increasing Usage of Self Glucose Monitoring among Population

Challenges:
Regulatory Guidelines on the Self Glucose Monitoring Manufacturers

Restraints:
Lack of Knowledge and Skills to use Self Glucose Monitoring

Opportunities:
Growing Demand for Self Glucose Monitoring from Individuals as well as Healthcare Sector

Market Leaders and their expansionary development strategies
In November 2020, LifeScan has announced the partnership with Shoppers Drug Mart Inc. The partnership to launch the Canadian retailer’s first digital diabetes management pilot program. The program is an opportunity to support Canadians living with diabetes with evidence-based and data-driven interventions.
In October 2021, LifeScan has launched OneTouch solutions. It is an e-commerce site a holistic digital health offering linking people with diabetes to solutions and support from proven experts. It can offer the critical support people need and ease the burdens of diabetes management for both the person with diabetes and their healthcare providers.
The US Food and Drug Administration (FDA), “It has become increasingly clear that the different use settings comprise distinct intended use populations with unique characteristics that can impact device design specifications, and that manufacturers should take the unique characteristics into account when designing their devices.”

Key Target Audience
Self Glucose Monitoring Manufacturers and Suppliers, Regulatory Bodies, Potential Investors, Research and Development Institutes and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Continuous Glucose Monitor (CGM)
  • Blood Glucose Meter
By Sales
  • Online
  • Offline

By Catagories
  • Blood-Glucose Meters
  • Blood Glucose Test Strips
  • Others

By Verticals
  • Patients
  • Doctors
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Usage of Self Glucose Monitoring among Population
    • 3.3. Market Challenges
      • 3.3.1. Regulatory Guidelines on the Self Glucose Monitoring Manufacturers
    • 3.4. Market Trends
      • 3.4.1. Growing Diabetic Patients
      • 3.4.2. Technological Advancement and Digitalization over the Globe
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Self Glucose Monitoring, by Type, Sales, Catagories, Verticals and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Self Glucose Monitoring (Value)
      • 5.2.1. Global Self Glucose Monitoring by: Type (Value)
        • 5.2.1.1. Continuous Glucose Monitor (CGM)
        • 5.2.1.2. Blood Glucose Meter
      • 5.2.2. Global Self Glucose Monitoring by: Sales (Value)
        • 5.2.2.1. Online
        • 5.2.2.2. Offline
      • 5.2.3. Global Self Glucose Monitoring by: Catagories (Value)
        • 5.2.3.1. Blood-Glucose Meters
        • 5.2.3.2. Blood Glucose Test Strips
        • 5.2.3.3. Others
      • 5.2.4. Global Self Glucose Monitoring by: Verticals (Value)
        • 5.2.4.1. Patients
        • 5.2.4.2. Doctors
        • 5.2.4.3. Others
      • 5.2.5. Global Self Glucose Monitoring Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Self Glucose Monitoring (Price)
      • 5.3.1. Global Self Glucose Monitoring by: Type (Price)
  • 6. Self Glucose Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Diabetes Québec (Diabète Québec) (Canada)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. LifeScan (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hoffmann-La Roche AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtronic (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ascensia Diabetes Care (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Tandem Diabetes Care (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dexcom Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. SocialDiabetes (Spain)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. One Drop (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. H2 Inc. (Taiwan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Self Glucose Monitoring Sale, by Type, Sales, Catagories, Verticals and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Self Glucose Monitoring (Value)
      • 7.2.1. Global Self Glucose Monitoring by: Type (Value)
        • 7.2.1.1. Continuous Glucose Monitor (CGM)
        • 7.2.1.2. Blood Glucose Meter
      • 7.2.2. Global Self Glucose Monitoring by: Sales (Value)
        • 7.2.2.1. Online
        • 7.2.2.2. Offline
      • 7.2.3. Global Self Glucose Monitoring by: Catagories (Value)
        • 7.2.3.1. Blood-Glucose Meters
        • 7.2.3.2. Blood Glucose Test Strips
        • 7.2.3.3. Others
      • 7.2.4. Global Self Glucose Monitoring by: Verticals (Value)
        • 7.2.4.1. Patients
        • 7.2.4.2. Doctors
        • 7.2.4.3. Others
      • 7.2.5. Global Self Glucose Monitoring Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Self Glucose Monitoring (Price)
      • 7.3.1. Global Self Glucose Monitoring by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Self Glucose Monitoring: by Type(USD Million)
  • Table 2. Self Glucose Monitoring Continuous Glucose Monitor (CGM) , by Region USD Million (2018-2023)
  • Table 3. Self Glucose Monitoring Blood Glucose Meter , by Region USD Million (2018-2023)
  • Table 4. Self Glucose Monitoring: by Sales(USD Million)
  • Table 5. Self Glucose Monitoring Online , by Region USD Million (2018-2023)
  • Table 6. Self Glucose Monitoring Offline , by Region USD Million (2018-2023)
  • Table 7. Self Glucose Monitoring: by Catagories(USD Million)
  • Table 8. Self Glucose Monitoring Blood-Glucose Meters , by Region USD Million (2018-2023)
  • Table 9. Self Glucose Monitoring Blood Glucose Test Strips , by Region USD Million (2018-2023)
  • Table 10. Self Glucose Monitoring Others , by Region USD Million (2018-2023)
  • Table 11. Self Glucose Monitoring: by Verticals(USD Million)
  • Table 12. Self Glucose Monitoring Patients , by Region USD Million (2018-2023)
  • Table 13. Self Glucose Monitoring Doctors , by Region USD Million (2018-2023)
  • Table 14. Self Glucose Monitoring Others , by Region USD Million (2018-2023)
  • Table 15. South America Self Glucose Monitoring, by Country USD Million (2018-2023)
  • Table 16. South America Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 17. South America Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 18. South America Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 19. South America Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 20. Brazil Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 21. Brazil Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 22. Brazil Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 23. Brazil Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 24. Argentina Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 25. Argentina Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 26. Argentina Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 27. Argentina Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 28. Rest of South America Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 29. Rest of South America Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 30. Rest of South America Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 31. Rest of South America Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 32. Asia Pacific Self Glucose Monitoring, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 35. Asia Pacific Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 36. Asia Pacific Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 37. China Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 38. China Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 39. China Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 40. China Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 41. Japan Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 42. Japan Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 43. Japan Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 44. Japan Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 45. India Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 46. India Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 47. India Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 48. India Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 49. South Korea Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 50. South Korea Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 51. South Korea Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 52. South Korea Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 53. Australia Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 54. Australia Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 55. Australia Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 56. Australia Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 59. Rest of Asia-Pacific Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 60. Rest of Asia-Pacific Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 61. Europe Self Glucose Monitoring, by Country USD Million (2018-2023)
  • Table 62. Europe Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 63. Europe Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 64. Europe Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 65. Europe Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 66. Germany Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 67. Germany Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 68. Germany Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 69. Germany Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 70. France Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 71. France Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 72. France Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 73. France Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 74. Italy Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 75. Italy Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 76. Italy Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 77. Italy Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 78. United Kingdom Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 79. United Kingdom Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 80. United Kingdom Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 81. United Kingdom Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 82. Netherlands Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 83. Netherlands Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 84. Netherlands Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 85. Netherlands Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 86. Rest of Europe Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 87. Rest of Europe Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 88. Rest of Europe Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 89. Rest of Europe Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 90. MEA Self Glucose Monitoring, by Country USD Million (2018-2023)
  • Table 91. MEA Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 92. MEA Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 93. MEA Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 94. MEA Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 95. Middle East Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 96. Middle East Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 97. Middle East Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 98. Middle East Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 99. Africa Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 100. Africa Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 101. Africa Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 102. Africa Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 103. North America Self Glucose Monitoring, by Country USD Million (2018-2023)
  • Table 104. North America Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 105. North America Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 106. North America Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 107. North America Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 108. United States Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 109. United States Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 110. United States Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 111. United States Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 112. Canada Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 113. Canada Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 114. Canada Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 115. Canada Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 116. Mexico Self Glucose Monitoring, by Type USD Million (2018-2023)
  • Table 117. Mexico Self Glucose Monitoring, by Sales USD Million (2018-2023)
  • Table 118. Mexico Self Glucose Monitoring, by Catagories USD Million (2018-2023)
  • Table 119. Mexico Self Glucose Monitoring, by Verticals USD Million (2018-2023)
  • Table 120. Self Glucose Monitoring: by Type(USD/Units)
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Self Glucose Monitoring: by Type(USD Million)
  • Table 132. Self Glucose Monitoring Continuous Glucose Monitor (CGM) , by Region USD Million (2025-2030)
  • Table 133. Self Glucose Monitoring Blood Glucose Meter , by Region USD Million (2025-2030)
  • Table 134. Self Glucose Monitoring: by Sales(USD Million)
  • Table 135. Self Glucose Monitoring Online , by Region USD Million (2025-2030)
  • Table 136. Self Glucose Monitoring Offline , by Region USD Million (2025-2030)
  • Table 137. Self Glucose Monitoring: by Catagories(USD Million)
  • Table 138. Self Glucose Monitoring Blood-Glucose Meters , by Region USD Million (2025-2030)
  • Table 139. Self Glucose Monitoring Blood Glucose Test Strips , by Region USD Million (2025-2030)
  • Table 140. Self Glucose Monitoring Others , by Region USD Million (2025-2030)
  • Table 141. Self Glucose Monitoring: by Verticals(USD Million)
  • Table 142. Self Glucose Monitoring Patients , by Region USD Million (2025-2030)
  • Table 143. Self Glucose Monitoring Doctors , by Region USD Million (2025-2030)
  • Table 144. Self Glucose Monitoring Others , by Region USD Million (2025-2030)
  • Table 145. South America Self Glucose Monitoring, by Country USD Million (2025-2030)
  • Table 146. South America Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 147. South America Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 148. South America Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 149. South America Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 150. Brazil Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 151. Brazil Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 152. Brazil Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 153. Brazil Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 154. Argentina Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 155. Argentina Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 156. Argentina Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 157. Argentina Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 158. Rest of South America Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 159. Rest of South America Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 160. Rest of South America Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 161. Rest of South America Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 162. Asia Pacific Self Glucose Monitoring, by Country USD Million (2025-2030)
  • Table 163. Asia Pacific Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 164. Asia Pacific Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 165. Asia Pacific Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 166. Asia Pacific Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 167. China Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 168. China Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 169. China Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 170. China Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 171. Japan Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 172. Japan Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 173. Japan Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 174. Japan Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 175. India Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 176. India Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 177. India Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 178. India Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 179. South Korea Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 180. South Korea Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 181. South Korea Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 182. South Korea Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 183. Australia Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 184. Australia Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 185. Australia Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 186. Australia Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 187. Rest of Asia-Pacific Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 188. Rest of Asia-Pacific Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 189. Rest of Asia-Pacific Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 190. Rest of Asia-Pacific Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 191. Europe Self Glucose Monitoring, by Country USD Million (2025-2030)
  • Table 192. Europe Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 193. Europe Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 194. Europe Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 195. Europe Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 196. Germany Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 197. Germany Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 198. Germany Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 199. Germany Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 200. France Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 201. France Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 202. France Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 203. France Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 204. Italy Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 205. Italy Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 206. Italy Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 207. Italy Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 208. United Kingdom Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 209. United Kingdom Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 210. United Kingdom Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 211. United Kingdom Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 212. Netherlands Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 213. Netherlands Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 214. Netherlands Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 215. Netherlands Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 216. Rest of Europe Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 217. Rest of Europe Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 218. Rest of Europe Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 219. Rest of Europe Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 220. MEA Self Glucose Monitoring, by Country USD Million (2025-2030)
  • Table 221. MEA Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 222. MEA Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 223. MEA Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 224. MEA Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 225. Middle East Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 226. Middle East Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 227. Middle East Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 228. Middle East Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 229. Africa Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 230. Africa Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 231. Africa Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 232. Africa Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 233. North America Self Glucose Monitoring, by Country USD Million (2025-2030)
  • Table 234. North America Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 235. North America Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 236. North America Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 237. North America Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 238. United States Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 239. United States Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 240. United States Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 241. United States Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 242. Canada Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 243. Canada Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 244. Canada Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 245. Canada Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 246. Mexico Self Glucose Monitoring, by Type USD Million (2025-2030)
  • Table 247. Mexico Self Glucose Monitoring, by Sales USD Million (2025-2030)
  • Table 248. Mexico Self Glucose Monitoring, by Catagories USD Million (2025-2030)
  • Table 249. Mexico Self Glucose Monitoring, by Verticals USD Million (2025-2030)
  • Table 250. Self Glucose Monitoring: by Type(USD/Units)
  • Table 251. Research Programs/Design for This Report
  • Table 252. Key Data Information from Secondary Sources
  • Table 253. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Self Glucose Monitoring: by Type USD Million (2018-2023)
  • Figure 5. Global Self Glucose Monitoring: by Sales USD Million (2018-2023)
  • Figure 6. Global Self Glucose Monitoring: by Catagories USD Million (2018-2023)
  • Figure 7. Global Self Glucose Monitoring: by Verticals USD Million (2018-2023)
  • Figure 8. South America Self Glucose Monitoring Share (%), by Country
  • Figure 9. Asia Pacific Self Glucose Monitoring Share (%), by Country
  • Figure 10. Europe Self Glucose Monitoring Share (%), by Country
  • Figure 11. MEA Self Glucose Monitoring Share (%), by Country
  • Figure 12. North America Self Glucose Monitoring Share (%), by Country
  • Figure 13. Global Self Glucose Monitoring: by Type USD/Units (2018-2023)
  • Figure 14. Global Self Glucose Monitoring share by Players 2023 (%)
  • Figure 15. Global Self Glucose Monitoring share by Players (Top 3) 2023(%)
  • Figure 16. Global Self Glucose Monitoring share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Diabetes Québec (Diabète Québec) (Canada) Revenue, Net Income and Gross profit
  • Figure 19. Diabetes Québec (Diabète Québec) (Canada) Revenue: by Geography 2023
  • Figure 20. LifeScan (United States) Revenue, Net Income and Gross profit
  • Figure 21. LifeScan (United States) Revenue: by Geography 2023
  • Figure 22. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2023
  • Figure 24. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 26. Ascensia Diabetes Care (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Ascensia Diabetes Care (Switzerland) Revenue: by Geography 2023
  • Figure 28. Tandem Diabetes Care (United States) Revenue, Net Income and Gross profit
  • Figure 29. Tandem Diabetes Care (United States) Revenue: by Geography 2023
  • Figure 30. Dexcom Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Dexcom Inc. (United States) Revenue: by Geography 2023
  • Figure 32. SocialDiabetes (Spain) Revenue, Net Income and Gross profit
  • Figure 33. SocialDiabetes (Spain) Revenue: by Geography 2023
  • Figure 34. One Drop (United States) Revenue, Net Income and Gross profit
  • Figure 35. One Drop (United States) Revenue: by Geography 2023
  • Figure 36. H2 Inc. (Taiwan) Revenue, Net Income and Gross profit
  • Figure 37. H2 Inc. (Taiwan) Revenue: by Geography 2023
  • Figure 38. Global Self Glucose Monitoring: by Type USD Million (2025-2030)
  • Figure 39. Global Self Glucose Monitoring: by Sales USD Million (2025-2030)
  • Figure 40. Global Self Glucose Monitoring: by Catagories USD Million (2025-2030)
  • Figure 41. Global Self Glucose Monitoring: by Verticals USD Million (2025-2030)
  • Figure 42. South America Self Glucose Monitoring Share (%), by Country
  • Figure 43. Asia Pacific Self Glucose Monitoring Share (%), by Country
  • Figure 44. Europe Self Glucose Monitoring Share (%), by Country
  • Figure 45. MEA Self Glucose Monitoring Share (%), by Country
  • Figure 46. North America Self Glucose Monitoring Share (%), by Country
  • Figure 47. Global Self Glucose Monitoring: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Diabetes Québec (Diabète Québec) (Canada)
  • LifeScan (United States)
  • Hoffmann-La Roche AG (Switzerland)
  • Medtronic (Ireland)
  • Ascensia Diabetes Care (Switzerland)
  • Tandem Diabetes Care (United States)
  • Dexcom Inc. (United States)
  • SocialDiabetes (Spain)
  • One Drop (United States)
  • H2 Inc. (Taiwan)
Additional players considered in the study are as follows:
Dottli (Finland) , Others
Select User Access Type

Key Highlights of Report


Mar 2024 211 Pages 80 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Diabetes Québec (Diabète Québec) (Canada), LifeScan (United States), Hoffmann-La Roche AG (Switzerland), Medtronic (Ireland), Ascensia Diabetes Care (Switzerland), Tandem Diabetes Care (United States), Dexcom Inc. (United States), SocialDiabetes (Spain), One Drop (United States) and H2 Inc. (Taiwan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Diabetic Patients " is seen as one of major influencing trends for Self Glucose Monitoring Market during projected period 2023-2030.
The Self Glucose Monitoring market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Self Glucose Monitoring Report?